Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico · Delayed Price · Currency is MXN 77.90
-4.70 (-5.69%)
At close: Jan 20, 2026
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $5.18M USD in the quarter ending September 30, 2025, a decrease of -80.16%. This brings the company's revenue in the last twelve months to $43.69M, down -32.98% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm)
$43.69M
Revenue Growth
-32.98%
P/S Ratio
50.28
Revenue / Employee
$54.61K
Employees
800
Market Cap
40.29B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.84M | 14.26M | 32.00% |
| Dec 31, 2023 | 44.58M | 4.73M | 11.88% |
| Dec 31, 2022 | 39.84M | 29.67M | 291.46% |
| Dec 31, 2021 | 10.18M | 6.22M | 156.89% |
| Dec 31, 2020 | 3.96M | 1.64M | 70.85% |
| Dec 31, 2019 | 2.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orbia Advance Corporation | 138.01B |
| Grupo Aeroméxico | 98.27B |
| Alsea | 83.44B |
| Grupo Gigante, S. A. B. de C. V. | 35.74B |
| Grupo Lamosa | 35.13B |
| Grupo Profuturo | 31.87B |
| Fibra Danhos | 7.45B |
| FIBRA Terrafina | 4.99B |